News | June 04, 2014

New Performance Metrics for Cath PCI Accreditation Published by Accreditation for Cardiovascular Excellence

New performance metrics support quality standards for interventional cardiology best practices

June 4, 2014 — The Accreditation for Cardiovascular Excellence (ACE) Board of Directors has approved a new set of Performance Metrics for Cath PCI Accreditation. These metrics have been published and are now available for download on the ACE website or are available in hard copy.

ACE updated its Cath/PCI performance metrics to align with the NCDR CathPCI Registry, NCDR ACTION Registry and the Hospital Compare data. Thirty-six performance metrics in PCI, Diagnostic Cath, STEMI/NSTEMI and Medicare Hospital Compare Outcomes have been updated.

"It is critically important to align performance metrics with cath lab documentation," said Gregory J. Dehmer, M.D., FACC, FACP, FAHA, FSCAI and ACE board chair. "Incorporating these performance metrics into the ACE accreditation program maintains best practices for interventional cardiology."

SCAI 2013-14 President Ted A. Bass, M.D., FSCAI, is a long-time advocate of efforts, such as ACE's, that promote adherence to quality standards in cardiac cath labs. "I am excited by the rapidly growing number of cath labs that are applying for ACE review and accreditation," said Bass. "Cath lab accreditation is becoming a must-have for interventional cardiology labs."

For more information: www.cvexcel.org

Related Content

Videos | Cath Lab| January 04, 2018
Bernadette Speiser, BSN, MSN, CCRN, RCIS, a cardiac cath/EP nurse at Palo Alto Veterans Hospital, Palo Alto, Calif.,
FDA Initiates Class I Recall of Sterilmed Reprocessed Agilis Steerable Introducer Sheath
News | Cath Lab| January 04, 2018
The U.S. Food and Drug Administration (FDA) announced a Class I recall of Sterilmed’s Agilis Steerable Introducer...
The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA atherectomy system. Athar Ansari, M.D.

The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA system. 

Feature | Cath Lab| November 24, 2017 | Athar Ansari, M.D., FACC
As debates about the current state and future of healthcare rage in Congress, the media and healthcare settings acros
Videos | Cath Lab| November 08, 2017
Juan Granada, M.D., Cardiovascular Research Foundation president and chief executive officer, shares his insights on
Results of the ORBITA study found no difference in exercise time after six weeks in patients with stable angina who received percutaneous coronary intervention (PCI) versus a placebo treatment. TCT 2017
Feature | Cath Lab| November 06, 2017
November 6, 2017 – Results from ORBITA, a prospective multi-center randomized blinded placebo-controlled study, found
Culprit Lesion-Only PCI Improves Outcomes for Cardiogenic Shock Patients Compared to Multivessel PCI
News | Cath Lab| November 01, 2017
November 1, 2017 — Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found an initial strateg
Three-Year Quality of Life Improvements Similar for PCI and CABG in Left Main Disease
News | Cath Lab| October 30, 2017
October 30, 2017 — New study results from the EXCEL trial comparing the quality of life (QoL) of patients with left m
Corindus Evaluates Incorporating HeartFlow Technology With CorPath GRX System
Technology | Cath Lab| October 26, 2017
Corindus Vascular Robotics Inc. announced that it will incorporate the HeartFlow FFRct (fractional flow reserve-...
Shockwave Medical Announces $35 Million in New Financing
News | Cath Lab| October 24, 2017
October 24, 2017 — Shockwave Medical reported $35 million in new financing, an extension of the company’s previously
Overlay Init